LifeTech Scientific Corp. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
200.00
216.00
196.00
441.00
402.00
275.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
128.00
-20.00
-19.00
-75.00
139.00
74.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
617.00
372.00
476.00
470.00
604.00
360.00
Cash Flow from Investing Activities
-82.00
-539.00
-502.00
-551.00
-101.00
-373.00
Cash Flow from Financing Activities
-427.00
-166.00
189.00
-251.00
-327.00
768.00
Net Cash Inflow / Outflow
110.00
-334.00
160.00
-331.00
177.00
755.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
1.00
0.00
-1.00
0.00
2.00
1.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of LifeTech Scientific Corp.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
200.913377043706
-274.465752045628
474.00
173.20%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
128.021476773892
7.72072187617437
121.00
1558.15%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
617.91912022779
-40.4136788866079
657.00
1628.99%
Cash Flow from Investing Activities
-82.2914643238906
2.842535754664
-84.00
-2995.00%
Cash Flow from Financing Activities
-427.062528400819
73.8343510787964
-500.00
-678.41%
Net Cash Inflow / Outflow
110.123587586813
30.2798925105757
80.00
263.69%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
1.55846008373219
-5.98331543627673
6.00
126.05%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is 65.92% vs -21.77% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
617.92
372.42
65.92%






